Blue Cross | Blue Shield | Blue Care Network of Michigan The Record

Stethoscope with RX papers

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article
July 2020

Starting July 1, 2020, Praluent and Repatha will no longer be designated as specialty drugs

Starting July 1, 2020, the PCSK9 inhibitor drugs Repatha® and Praluent® will no longer be designated as specialty drugs. This means members can fill prescriptions for these drugs at any retail pharmacy in our network. And, if their prescription drug benefit allows it, they can fill a 90-day supply.

Specialty drugs require special handling, administration or monitoring. Some can only be filled by a specialty pharmacy.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2019 American Medical Association. All rights reserved.
Blue Cross Blue Shield of Michigan and Blue Care Network are nonprofit corporations and
independent licensees of the Blue Cross and Blue Shield Association.